# Research Logic Matrix: Inter-Axis Interaction

> æ—¨åœ¨æ­ç¤ºä¸åŒç ”ç©¶è½´çº¿ (Axis A-D) ä¹‹é—´çš„æ·±å±‚å…³è”ï¼Œå¯»æ‰¾æœ€å…·æ½œåŠ›çš„å¹²é¢„ç‚¹ã€‚

## 1. ç³»ç»Ÿæ€§äº¤äº’çŸ©é˜µ (Interaction Matrix)

| | Axis A (è›‹ç™½ç¨³æ€) | Axis B (ç¥ç»å…ç–«) | Axis C (å…¨èº«ç³»ç»Ÿ) |
| :--- | :--- | :--- | :--- |
| **Axis A** | **åˆçº§æˆæ ¸ (Primary Nucleation)** | æ–‘å—æ´»åŒ– Microglia | è‚è„/ç±»æ·‹å·´æ¸…é™¤ç‡ |
| **Axis B** | åå™¬ä½œç”¨å¹²æ‰° AÎ² åŠ¨åŠ›å­¦ | **DAM çŠ¶æ€åˆ‡æ¢** | å¤–å‘¨ T ç»†èƒæ¸—é€ |
| **Axis C** | ä»£è°¢ç‰©è¯±å¯¼ AÎ² æ²‰é™ | èŒç¾¤è°ƒèŠ‚å…ç–«è¡¨å‹ | **åŸºå› é‡ç¼–ç¨‹ (Genomic Reset)** |

## 2. æ ¸å¿ƒç ”ç©¶æƒ…æŠ¥é“¾ (Intelligence Chain)

```text
   [ ğŸƒ Systemic Axis C ] â”€â”€(Factors)â”€â”€> [ ğŸ§± BBB Integrity ] â”€â”€â”€â”
                                                                 â”‚
                                                                 â–¼
   [ ğŸ§ª Proteostasis Axis A ] â—€â”€â”€(Action)â”€â”€ [ ğŸ›¡ï¸ Glia Axis B ] â—€â”€â”€â”˜
             â”‚                                     â”‚
             â”‚(Control)                            â”‚(Modulate)
             â”‚                                     â”‚
             â–¼                                     â–¼
   [ ğŸ“‰ Nucleation Rate ] â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€> [ ğŸ§  Delayed Decline ]
             â”‚                                     â”‚
             â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€[ ğŸ¤– AI Axis D/F ]â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## 3. 2025+ ä¼˜å…ˆçº§ç ”ç©¶å‡è®¾ (High-Priority Hypotheses)

1.  **ç‰©ç†æ€§æ¸…é™¤ä¸å…ç–«ååŒ**ï¼šåˆ©ç”¨å£°æ³¢å¹²é¢„åŠ é€Ÿ Glymphatic æ¸…é™¤ (Axis A) æ—¶ï¼Œæ˜¯å¦ä¼šè§¦å‘ç‰¹å®šçš„ Microglia æŠ—ç‚è¡¨å‹ (Axis B)ï¼Ÿ
2.  **ç²¾å‡†åŸºå› é‡ç¼–ç¨‹**ï¼šè¿åŠ¨è¯±å¯¼çš„ Irisin æ˜¯å¦èƒ½ç‰¹å¼‚æ€§åœ°å…³é—­ä¸ Tau èšåˆç›¸å…³çš„è½¬å½•å› å­ (Axis A + C)ï¼Ÿ
3.  **T ç»†èƒæŠ—åŸå±è”½**ï¼šé€šè¿‡è¯ç‰©å±è”½æ–‘å—å‘¨å›´çš„è¶‹åŒ–å› å­ä½ç‚¹ï¼Œèƒ½å¦åœ¨ä¸å½±å“å…¨èº«å…ç–«çš„æƒ…å†µä¸‹é˜»æ–­è„‘å†…ç‚ç—‡ (Axis B)ï¼Ÿ

## 4. å‚è€ƒæ–‡çŒ® (References)
- **Zhen, X., et al. (2024).** GSDMD activation is the key molecular mechanism of inflammatory blood-brain barrier disruption. *Nature*.
- **Meisl, G., et al. (2024).** In vivo rate-determining steps of tau aggregation in Alzheimer's disease. *Cell*.
- **Kim, S., et al. (2024).** Gut-brain axis modulation of microglia states in neurodegeneration. *Cell*.

---
[å›åˆ°ç›®å½•](../README.md)
